[1] Tian Z, Li L, Wang L, et al.Salivary gland neoplasms in oral and maxillofacial regions: a 23-year retrospective study of 6982 cases in an eastern Chinese population[J]. Int J Oral Maxillofac Surg, 2010, 39(3): 235-242. [2] Roh JL, Park CI.Gland-preserving surgery for pleomorphic adenoma in the submandibular gland[J]. Br J Surg, 2008, 95(10): 1252-1256. [3] Tanahashi J, Daa T, Kashima K, et al.Carcinosarcoma ex recurrent pleomorphic adenoma of the submandibular gland[J]. APMIS, 2007, 115(6): 789-794. [4] Buva KB, Deshmukh AA, Deshmukh AA. A case report of rare carcinoma ex pleomorphic adenoma of submandibular gland and its detailed description [J]. J Clin Diagn Res, 2017, 11(5): ZD15-ZD17. [5] 朱声荣, 王秀丽, 邵乐南, 等. 颌下腺多形性腺瘤及其复发的临床研究[J]. 口腔医学研究, 2006, 22(3): 290-291. [6] Wittekindt C, Streubel K, Arnold G, et al.Recurrent pleomorphic adenoma of the parotid gland: analysis of 108 consecutive patients[J]. Head Neck, 2007, 29(9): 822-828. [7] Witt RL, Eisele DW, Morton RP, et al.Etiology and management of recurrent parotid pleomorphic adenoma[J]. Laryngoscope, 2015, 125(4): 888-893. [8] 邓刚, 李晓光, 何悦, 等. 复发性腮腺多形性腺瘤的手术治疗及并发症预防[J]. 中国口腔颌面外科杂志, 2017, 15(3): 227-230. [9] Jakobiec FA, Stagner AM, Eagle RC Jr, et al.Unusual pleomorphic adenoma of the lacrimal Gland: Immunohistochemical demonstration of PLAG1 and HMGA2 oncoproteins[J]. Surv Ophthalmol, 2017, 62(2): 219-226. [10] North AF, Levin LS, Hansen LS.Recurrent mixed tumor (pleomorphic adenoma) of the palate: A case report[J]. J Md State Dent Assoc, 1984, 27(2): 76-78. [11] Kinawi MM, Aidaros SM.A case of recurrent mixed tumour of the cheek in a girl aged 1 1/2 years[J]. J Egypt Med Assoc, 1949, 32(1): 69-72. [12] Zamolo G, Coklo M, Petkovic M, et al.Recurrent pleomorphic adenoma of epipharynx following irradiation therapy[J]. Coll Antropol, 2005, 29(1): 185-187. [13] Larian B.Parotidectomy for benign parotid tumors[J]. Otolaryngol Clin North Am, 2016, 49(2): 395-413. [14] Suh MW, Hah JH, Kwon SK, et al.Clinical manifestations of recurrent parotid pleomorphic adenoma[J]. Clin Exp Otorhinolaryngol, 2009, 2(4): 193-197. [15] Redaelli de Zinis LO, Piccioni M, Antonelli AR, et al. Management and prognostic factors of recurrent pleomorphic adenoma of the parotid gland: personal experience and review of the literature[J]. Eur Arch Otorhinolaryngol, 2008, 265(4): 447-452. [16] Soares AB, Demasi AP, Altemani A, et al.Increased mucin 1 expression in recurrence and malignant transformation of salivary gland pleomorphic adenoma[J]. Histopathology, 2011, 58(3): 377-382. [17] Hamada T, Matsukita S, Goto M, et al.Mucin expression in pleomorphic adenoma of salivary gland: a potential role for MUC1 as a marker to predict recurrence[J]. J Clin Pathol, 2004, 57(8): 813-821. [18] Shen S, Yang W, Wang Z, et al.Tumor-initiating cells are enriched in CD44(hi) population in murine salivary gland tumor[J]. PLoS One, 2011, 6(8): e23282. [19] Soares AB, de Araujo VC, Juliano PB, et al. Angiogenic and lymphangiogenic microvessel density in recurrent pleomorphic adenoma[J]. J Oral Pathol Med, 2009, 38(8): 623-629. [20] de Souza AA, Altemani A, Passador-Santos F, et al. Dysregulation of the Rb pathway in recurrent pleomorphic adenoma of the salivary glands[J]. Virchows Arch, 2015, 467(3): 295-301. [21] Glas AS, Hollema H, Nap RE, et al.Expression of estrogen receptor, progesterone receptor, and insulin-like growth factor receptor-1 and of MIB-1 in patients with recurrent pleomorphic adenoma of the parotid gland[J]. Cancer, 2002,94(8): 2211-2216. [22] Johnson JT, Ferlito A, Fagan JJ, et al.Role of limited parotidectomy in management of pleomorphic adenoma[J]. J Laryngol Otol, 2007, 121(12): 1126-1128. |